EKZ-102, an experimental oral therapy for amyotrophic lateral sclerosis (ALS), is on track to enter early clinical testing in ...

The world's largest-ever clinical trial of treatments to slow or stop the progression of Parkinson's disease has launched, ...

In a breakthrough that could potentially rewrite the prevention and treatment of cancer, scientists have discovered how ...

The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other ...

The U.S. Food and Drug Administration has cleared another blood test that could help doctors identify whether memory problems ...

In 2024 Stephen Rich and his colleagues published a study in which they assessed the genetic risk of developing type 1 ...

1 in 100 people in Britain today live with rheumatoid arthritis (RA). Unlike osteoarthritis (OA), RA is caused not by wear and tear but by the body's immune system attacking its own joints. RA can ...

Dr. Sandip Patel discusses findings from a real-world study of biomarker testing in early-stage resected non-small cell lung ...

Elecsys’ approval could help boost the uptake of currently approved Alzheimer’s disease therapies, including Biogen’s ...

Buffalo Clinical Lab and Testing Center is leading a first-in-the-nation innovation, operating a clinical drug testing ...

It's been nearly three months since the U.S. government announced an outbreak of the bird flu virus on dairy farms. The World Health Organization considers the virus a public health concern because of ...